Tetra Radar · FDA Approvals · Decision date
Ameluz: FDA decision date
Biofrontera Inc. (BFRI) · 28 September 2026
Announced FDA’s completion of its filing review and filing acceptance of the Company’s supplemental New Drug Application (sNDA) for Ameluz ® PDT for the treatment of superficial basal cell carcinoma (sBCC), with a PDUFA target action date of September 28, 2026.
Source: 8-K of 14 May 2026
The date has passed; Tetra Radar has not recorded an approval.
Biofrontera Inc. on Tetra Radar
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.